Shared genetic architecture of cortical thickness alterations in major depressive disorder and schizophrenia

Prog Neuropsychopharmacol Biol Psychiatry. 2024 Dec 20:135:111121. doi: 10.1016/j.pnpbp.2024.111121. Epub 2024 Aug 21.

Abstract

Background: Major depressive disorder (MDD) and schizophrenia (SCZ) are heritable brain disorders characterized by alterations in cortical thickness. However, the shared genetic basis for cortical thickness changes in these disorders remains unclear.

Methods: We conducted a systematic literature search on cortical thickness in MDD and SCZ through PubMed and Web of Science. A coordinate-based meta-analysis was performed to identify cortical thickness changes. Additionally, utilizing summary statistics from the largest genome-wide association studies for depression (Ncase = 268,615, Ncontrol = 667,123) and SCZ (Ncase = 53,386, Ncontrol = 77,258), we explored shared genomic loci using conjunctional false discovery rate (conjFDR) analysis. Transcriptome-neuroimaging association analysis was then employed to identify shared genes associated with cortical thickness alterations, and enrichment analysis was finally carried out to elucidate the biological significance of these genes.

Results: Our search yielded 34 MDD (Ncase = 1621, Ncontrol = 1507) and 19 SCZ (Ncase = 1170, Ncontrol = 1043) neuroimaging studies for cortical thickness meta-analysis. Specific alterations in the left supplementary motor area were observed in MDD, while SCZ exhibited widespread reductions in various brain regions, particularly in the frontal and temporal areas. The conjFDR approach identified 357 genomic loci jointly associated with MDD and SCZ. Within these loci, 55 genes were found to be associated with cortical thickness alterations in both disorders. Enrichment analysis revealed their involvement in nervous system development, apoptosis, and cell communication.

Conclusion: This study revealed the shared genetic architecture underlying cortical thickness alterations in MDD and SCZ, providing insights into common neurobiological pathways. The identified genes and pathways may serve as potential transdiagnostic markers, informing precision medicine approaches in psychiatric care.

Keywords: Cortical thickness; Gene expression; Genome-wide association studies; Major depressive disorder; Schizophrenia.

Publication types

  • Meta-Analysis

MeSH terms

  • Brain Cortical Thickness
  • Cerebral Cortex* / diagnostic imaging
  • Cerebral Cortex* / pathology
  • Depressive Disorder, Major* / diagnostic imaging
  • Depressive Disorder, Major* / genetics
  • Depressive Disorder, Major* / pathology
  • Genome-Wide Association Study*
  • Humans
  • Neuroimaging
  • Schizophrenia* / diagnostic imaging
  • Schizophrenia* / genetics
  • Schizophrenia* / pathology